Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Monodora myristica extract is a botanical product derived from the seeds of the African Nutmeg tree (*Monodora myristica*), a plant native to Africa. It is primarily investigated in academic and preclinical research for its potential therapeutic applications in metabolic and inflammatory conditions. The extract contains a complex mixture of phytochemicals, including phenols, flavonoids, alkaloids, saponins, and cardiac glycosides. Research indicates that the extract may exert anti-diabetic effects by inhibiting key carbohydrate-digesting enzymes, specifically alpha-amylase and alpha-glucosidase, thereby helping to manage postprandial hyperglycemia. Additionally, it has demonstrated antioxidant properties through free radical scavenging and the prevention of lipid peroxidation in tissues such as the pancreas and liver. Preclinical studies have also explored its utility in treating hyperlipidemia, hepatotoxicity, diabetic nephropathy, and certain neurological or gastrointestinal symptoms. There are currently no commercial developers, IND filings, or registered clinical trials associated with this extract.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Monodora myristica extract.